Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

Recruiting

Observational StudyEvaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation

Sponsor:

Pennington Biomedical Research Center

Code:

NCT04207619

Conditions

Diabetes

Hypoglycemia

Eligibility Criteria

Sex: All

Age: 18 - 40

Healthy Volunteers: Accepted

Interventions

hyperinsulinemic-hypoglycemic clamp

13C-MRS procedure/Acetate infusion

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Pennington Biomedical Research Center on 2025-07-24.